 Administration (FDA)-approved
medicationsdcilostazol and pentoxifylline.90-92 Of note, a
recent review by the Royal College of Physicians in the
United Kingdom identiÔ¨Åes naftidrofuryldwidely available
in Europe but not FDA-approved in the United Statesdas
the drug of choice over both cilostazol and pentoxifylline
in the medical management of symptomatic PAD.93,